Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Everolimus for the Prevention of BK and CMV Viremia in HLA Sensitized Kidney Transplant Recipients

NCT01911546 is registered in ClinicalTrials.gov with Joseph Kahwaji, MD, MPH as lead sponsor.

NCT NCT01911546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01911546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Everolimus for the Prevention of BK and CMV Viremia in HLA Sensitized Kidney Transplant Recipients
Lead sponsor
Joseph Kahwaji, MD, MPH
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2013
Completion date
January 19, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

highly-sensitized kidney transplant recipients